Lawndale, NC, United States of America

Peter Jenkins

This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Immunophotonics, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Jenkins. Retrieved from https://idiyas.com/inventor/peter-jenkins-8mpoykdv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Peter Jenkins in Therapeutic Compositions

Introduction

Peter Jenkins is an accomplished inventor based in Lawndale, NC (US). He has made significant contributions to the field of therapeutic compositions, particularly through his innovative work involving chitosan-derived compositions. With a total of 3 patents, Jenkins has focused on developing methods for treating various neoplasms and medical disorders.

Latest Patents

Jenkins' latest patents include therapeutic compositions that utilize chitosan-derived materials. These compositions are designed to be effective agents when administered in connection with methods for treating neoplasms, including malignant lung, thyroid, and kidney neoplasms. His work emphasizes the potential of chitosan-derived compositions in addressing not only neoplasms but also other medical disorders.

Career Highlights

Throughout his career, Jenkins has been associated with Immunophotonics, Inc., where he has been able to apply his innovative ideas in a practical setting. His dedication to research and development has led to advancements in therapeutic applications that could benefit many patients.

Collaborations

Jenkins has collaborated with notable colleagues such as Tomas Hode and Robert E Nordquist. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of therapeutic compositions.

Conclusion

Peter Jenkins continues to be a pivotal figure in the development of innovative therapeutic solutions. His work with chitosan-derived compositions showcases his commitment to improving medical treatments and outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…